Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Youssef

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
JAMA Network Open|June 29, 2023
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in AustraliaClaire T Deakin, Bianca L De Stavola, Geoffrey Littlejohn, et al.
Rheumatology (Oxford, England)|October 16, 2012
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung diseaseOwen A Moore, Nicole Goh, Tamera Corte, et al.
Practical Radiation Oncology|November 1, 2023
Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast CancerAlison K Yoder, Tianlin Xu, Peter Youssef, et al.
Arthritis Research & Therapy|January 19, 2015
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosisYanjie Hao, Vivek Thakkar, Wendy Stevens, et al.
Clinical and Experimental Rheumatology|August 6, 2015
Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseOwen A Moore, Susanna M Proudman, Nicole Goh, et al.
Cell Reports|April 2, 2026
Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage functionRadjesh Bisoendial, Anna Kusienicka, Matthias Wielscher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional TherapyKate Gregory, Dylan Hansen, Ross Penglase, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2023
A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multicenter, Observational Cohort StudyAdelle S Jee, Iain Stewart, Peter Youssef, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
JAMA Network Open|June 29, 2023
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in AustraliaClaire T Deakin, Bianca L De Stavola, Geoffrey Littlejohn, et al.
Rheumatology (Oxford, England)|October 16, 2012
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung diseaseOwen A Moore, Nicole Goh, Tamera Corte, et al.
Practical Radiation Oncology|November 1, 2023
Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast CancerAlison K Yoder, Tianlin Xu, Peter Youssef, et al.
Arthritis Research & Therapy|January 19, 2015
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosisYanjie Hao, Vivek Thakkar, Wendy Stevens, et al.
Clinical and Experimental Rheumatology|August 6, 2015
Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseOwen A Moore, Susanna M Proudman, Nicole Goh, et al.
Cell Reports|April 2, 2026
Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage functionRadjesh Bisoendial, Anna Kusienicka, Matthias Wielscher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional TherapyKate Gregory, Dylan Hansen, Ross Penglase, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2023
A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multicenter, Observational Cohort StudyAdelle S Jee, Iain Stewart, Peter Youssef, et al.
Pageof 5